CodeMap® 
150 North Wacker Drive
Suite 2360
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2025
2024
QW Tests

Physician Fee Schedule

2025
2024

OPPS Fee Schedule

2025-January
2024-October

ASC Fee Schedule

2025-January
2024-October

APC Codes

2025-January
2024-October

DRG Codes

2025
2024

ASP Drug Pricing Files

2025-January
2024-October


CMS Transmittals



.

CodeMap® LCD-L35160

 

Printer Friendly Version

L35160
LCD for MolDX: Molecular Diagnostic Tests (MDT) (L35160)
See related Articles:
A54356-Billing and Coding: MolDX: Afirma™ Assay by Veracyte
A54386-Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update
A54418-Billing and Coding: MolDX: FDA-Approved BRAF Tests
A54422-Billing and Coding: MolDX: FDA-Approved EGFR Tests
A54445-Billing and Coding: MolDX: MammaPrint
A54480-Billing and Coding: MolDX: Oncotype DX® Breast Cancer Assay
A54484-Billing and Coding: MolDX: Oncotype DX® Colon Cancer
A54494-Billing and Coding: MolDx: ResponseDX Tissue of Origin®
A54498-Billing and Coding: MolDX: FDA-Approved KRAS Tests
A54552-Response to Comments: MolDX: Molecular Diagnostic Tests (MDT)
A55094-Billing and Coding: MolDX: ApoE Genotype
A55294-Billing and Coding: MolDX: Germline testing for use of PARP inhibitors
A55711-Billing and Coding: MolDX: Abbott RealTime IDH1 and IDH2 testing for Acute Myeloid Leukemia (AML)
A56103-Billing and Coding: MolDX: Microsatellite Instability-High (MSI-H) and Mismatch Repair Deficient (dMMR) Biomarker for Patients with Unresectable or Metastatic Solid Tumors
A57526-Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT)
A57842-Billing and Coding: MolDX: Short Tandem Repeat (STR) Markers and Chimerism (CPT® codes 81265-81268)
A59641-Billing and Coding: MolDX: Proteomics Testing

Contractor Information

Contractor Name: Noridian Healthcare Solutions, LLC - Full list of policies of this Medicare Contractor

Contractor Number: 01211

Contractor Type: MAC A

LCD Information

LCD ID Number: L35160 Status: A-Approved

LCD Title: MolDX: Molecular Diagnostic Tests (MDT)

Geographic Jurisdiction: American Samoa, Guam, Hawaii, Northern Mariana Islands Other Jurisdictions

Original Determination Effective Date: 10/01/2015

Original Determination Ending Date:

Revision Effective Date: 05/04/2023

Revision End Date:

CMS National Coverage Policy:

Title XVIII of the Social Security Act, §1862(a)(1)(A), states that no Medicare payment shall be made for items or services that "are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of malformed body member."

Title XVIII of the Social Security Act, §(a)(1)(D), Investigational or Experimental.

45 CFR §162.1002 (a)(5), Medical data code sets

CMS Internet-Only Manual, Pub. 100-08, Medicare Program Integrity Manual, Chapter 13, §13.5.4 Reasonable and Necessary Provisions in LCDs

 

 


Sorry, you need to login or register to view additional sections of this Medicare policy.

--
*


All information on this web site is compiled directly from information obtained from the Center for Medicare and Medicaid Services (CMS) and from its Contractors.

CodeMap® has made every reasonable effort to ensure the accuracy of the information contained on this web site. However, the ultimate responsibility for correct coding and claims submission lies with the provider of services. CodeMap® makes no representation, warranty, or guarantee that this compilation of Medicare information is error-free or that the use of this information will result in Medicare coverage and subsequent payment of claims. Final coverage and payment of claims are subject to many factors exclusively controlled by CMS and its contractors.

No part of this web page or data displayed may be redistibuted or used without the express written consent of Wheaton Partners, LLC.

03/15/2025 06:48:57 18.97.14.83

CodeMap® is a Registered Trademark of Wheaton Partners, LLC.